Exposure to air pollution is a major contributor to the development and exacerbation of breathing disorders, affecting populations across all age groups and geographic regions. Air pollution and breathing disorders are closely linked, with pollutants such as particulate matter, ozone, nitrogen dioxide, and volatile organic compounds triggering inflammatory responses in the respiratory system, impairing lung function, and increasing susceptibility to infections. Long-term exposure can lead to chronic conditions, including asthma, chronic obstructive pulmonary disease, and interstitial lung disease, while acute exposure may provoke exacerbations and respiratory distress. Vulnerable populations, such as children, the elderly, and individuals with pre-existing respiratory or cardiovascular conditions, are particularly at risk. Addressing this challenge requires a combination of public health policies, environmental monitoring, and community education to reduce pollutant exposure and raise awareness about respiratory risks. Clinical strategies include early diagnosis, management of pollutant-induced symptoms, and personalized care plans that consider environmental triggers. Research continues to explore the biological mechanisms through which air pollution affects lung tissue, aiming to develop targeted interventions and preventive measures. Additionally, technological solutions such as air quality sensors, urban planning to minimize exposure, and patient guidance on protective behaviors are increasingly integrated into respiratory care. By understanding the impact of environmental pollutants on respiratory health and implementing coordinated mitigation strategies, healthcare providers can reduce the burden of breathing disorders and enhance long-term lung health at both individual and population levels.
Title : Screening questionnaires for obstructive sleep apnea: An updated systematic review
Behzad Rahmati, Isfahan University of Medical Sciences, Iran (Islamic Republic of)
Title : Improving covid 19 candidate vaccine response through probiotics and micronutrient supplementation: Evaluating the role of TLR5
Zohre Eftekhari, Biotechnology Research Center, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Iatrogenic pneumothorax following nephrectomy: Case report
Chaimae Tahiri, National University Hospital Center of Fann, Senegal